Wake Forest School of Medicine
At a Glance
1
Educational Resources Posted
8
Consortium News Stories Posted
6
Events Posted
1
Opportunities Posted
57
Publications citing CTSA Program Grant
23
Users from Hub Registered
UL1 Award
KL2 Award
TL1 Award
UL1
UL1 Director
DonaldMcClainDirector, Clinical & Translation Science InstituteUL1 Administrator
Education
Education Contact
KL2 Director
KL2 Administrator
TL1 Administrator
Communications
Communications Representative
Enterprise Committees
Integration Across Lifespan Voting Member
DonaldMcClainDirector, Clinical & Translation Science InstituteInformatics Voting Member
Collaboration and Engagement Voting Member
Common Metrics
Primary CM Contact
-
DonaldMcClainDirector, Clinical & Translation Science Institute
ChristopherO'ByrneVice President & Associate Dean, Research Administration and Operations
Consortium News
Wake Forest demonstrates how a health care system can more quickly turn research outcomes into patient care with a new blood pressure measurement protocol that may help prevent strokes and cardiovascular events.
Equipping Faculty at Wake Forest and Beyond When asked the vision behind CTSI’s Mentor Academy, Claudia Olivier, PhD responded: “Every mentor needs some level of training on how to be a good—a great—mentor.” Dr. Olivier serves as co-facilitator of the 6-month Mentor Academy cohorts alongside faculty Program Leader Debra Diz, PhD. Initially created for mid-career faculty, the Mentor Academy has
Educational Content
Events
KL2 awardees from Clinical and Translational Science Centers (CTSA) present virtual lectures as part of the CTSA Visiting Scholar Program. Kirsten M. Wright, ND, MCR, MS from Oregon Health and Science University hosted by Wake Forest School of Medicine will present her research on "Using a Home-Based Monitoring Platform to Explore Real-World Routines and Nutrition Behavior in Older Adults at Risk
Opportunities
Poster Sessions
During this unprecedented time of the COVID-19 pandemic, Wake Forest’s Clinical and Translational Science Institute (CTSI) has navigated significant challenges the pandemic has presented to best support our research community. Our poster will communicate several areas where our CTSI has promoted COVID-19 research activities, facilitated the implementation of research new policies impacted by COVID
Kylie Kavanagh, Matthew J. Jorgensen, J. Mark Cline, D. McClain The goal of Wake Forest (WF) Nonhuman Primate (NHP) Signature Program is to accelerate translational research by providing access to the ultimate translational animal model. NHP have served as an extremely successful preclinical platform that has allowed the bidirectional flow of knowledge from scientists to clinicians and back to
Publications
Caregiver engagement practices in National Cancer Institute Clinical Oncology Research Program settings: Implications for research to advance the field
Supportive care interventions have demonstrated benefits for both informal and/or family cancer caregivers and their patients, but uptake generally is poor. To the authors' knowledge, little is known regarding the availability of supportive care services in community oncology practices, as well as
Neurologist prescribing versus psychiatry referral: Examining patient preferences for anxiety and depression management in a symptomatic epilepsy clinic sample
Anxiety and depression symptoms in epilepsy are common, impactful and under-recognized and undertreated. While prior survey data suggests equipoise among epileptologists for managing anxiety and/or depression via prescribing in the epilepsy clinic versus psychiatry referral, patient preferences are
Preferences for breast cancer survivorship care by rural/urban residence and age at diagnosis
Preferences for survivorship care among recently treated breast cancer survivors may vary by rural-urban residence and age, but potential differences have not been examined. We conducted a cross-sectional survey of survivorship preferences among women treated for non-metastatic breast cancer 6-24